Skip Navigation

Vaccine Safety Bibliography-February 2014

1. Recommended immunization schedule for adults in Korea, by the Korean Society of Infectious Diseases, 2012. Clin Exp Vaccine Res. 2014 Jan;3(1):110-2.

2. Abdelnour A, Silas PE, Lamas MR, Aragón CF, Chiu NC, Chiu CH, Acuña TH, Castrejón Tde L, Izu A, Odrljin T, Smolenov I, Hohenboken M, Dull PM. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants. Vaccine. 2014 Feb 12;32(8):965-72.

3. Afonso N, Kavanagh M, Swanberg S. Improvement in attitudes toward influenza vaccination in medical students following an integrated curricular intervention. Vaccine. 2014 Jan 16;32(4):502-6.

4. Agbenu E, Chartier Y, Eleeza J, Antwi-Agyei KO, Diamenu S, Ronveaux O, Perea W. Use of Hub Cutters and the Volume of Sharp Waste and Occurrence of Needle-Stick Injuries during 2011 Mass Immunization Campaigns against Yellow Fever in Ghana: A Cohort Study. Int J Occup Environ Med. 2014 Jan;5(1):9-17.

5. Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L. Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis. 2014 Jan;58(1):50-7.

6. Ahout I, Ferwerda G, de Groot R. Influenza vaccination in kids, are you kidding me? J Infect. 2014 Jan;68 Suppl 1:S100-7.

7. Albright K, Saville A, Lockhart S, Widmer Racich K, Beaty B, Kempe A. Provider attitudes toward public-private collaboration to improve immunization reminder/recall: a mixed-methods study. Acad Pediatr. 2014 Jan-Feb;14(1):62-70.

8. Aliberti S, Mantero M, Mirsaeidi M, Blasi F. Role of vaccination in preventing pneumococcal disease in adults. Clin Microbiol Infect. 2014 Jan 10. [Epub ahead of print].

9. Antachopoulos C, Tsolia MN, Tzanakaki G, Xirogianni A, Dedousi O, Markou G, Zografou SM, Eliades A, Kirvassilis F, Kesanopoulos K, Roilides E. Parapneumonic  Pleural Effusions Caused by Streptococcus pneumoniae Serotype 3 in Children Immunized with 13-Valent Conjugated Pneumococcal Vaccine. Pediatr Infect Dis J. 2014 Jan;33(1):81-3.

10. Antrobus RD, Berthoud TK, Mullarkey CE, Hoschler K, Coughlan L, Zambon M, Hill AV, Gilbert SC. Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses. Mol Ther. 2014 Jan;22(1):233-8.

11. Anwar E, Goldberg E, Fraser A, Acosta CJ, Paul M, Leibovici L. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. 2014 Jan 2;1:CD001261. [Epub ahead of print].

12. Aziz AM. The case for flu vaccination for health professionals. Br J Nurs. 2014 Jan 23;23(2):74.

13. Bajracharya D, Khan MI, Pach A 3rd, Shrestha P, Joshi N, Upreti SR, Wierzba T, Puri M, Sahastrabuddhe S, Ochiai RL. 25 years after vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal. PLoS One. 2014 Jan 6;9(1):e77974.

14. Bakare MO, Okoye JO, Obindo JT. Introducing depression and developmental screenings into the National Programme on Immunization (NPI) in southeast Nigeria: an experimental cross-sectional assessment. Gen Hosp Psychiatry. 2014 Jan-Feb;36(1):105-12.

15. Bamberger EE, Ben-Shimol S, Abu Raya B, Katz A, Givon-Lavi N, Dagan R, Srugo I; on behalf of the Israeli Pediatric Bacteremia and Meningitis Group. Pediatric Invasive Haemophilus influenzae Infections in Israel in the Era of Haemophilus influenzae type b Vaccine: A Nationwide Prospective Study. Pediatr Infect Dis J.  2014 Jan 20. [Epub ahead of print].

16. Becker-Dreps S, Amaya E, Liu L, Moreno G, Rocha J, Briceño R, Alemán J, Hudgens MG, Woods CW, Weber DJ. Changes in Childhood Pneumonia and Infant Mortality Rates Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Nicaragua. Pediatr Infect Dis J. 2014 Jan 17. [Epub ahead of print].


17. Bednarczyk RA, Curran EA, Orenstein WA, Omer SB. Health disparities in human papillomavirus vaccine coverage: trends analysis from the national immunization survey-teen, 2008-2011. Clin Infect Dis. 2014 Jan;58(2):238-41.

18. Beltrán-Beck B, Romero B, Sevilla IA, Barasona JA, Garrido JM, González-Barrio D, Díez-Delgado I, Minguijón E, Casal C, Vicente J, Gortázar C, Aranaz A. Assessment of an oral Mycobacterium bovis BCG vaccine and an inactivated M. bovis preparation for wild boar in terms of adverse reactions, vaccine strain survival, and uptake by nontarget species. Clin Vaccine Immunol. 2014 Jan;21(1):12-20.

19. Bhuiyan TR, Choudhury FK, Khanam F, Saha A, Sayeed MA, Salma U, Lundgren A, Sack DA, Svennerholm AM, Qadri F. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Vaccine. 2014 Jan 15. [Epub ahead of print].

20. Bingham CO 3rd, Rizzo W, Kivitz A, Hassanali A, Upmanyu R, Klearman M. Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Ann Rheum Dis. 2014 Jan 21. [Epub ahead of print].

21. Biscayart C, Carrega ME, Sagradini S, Gentile A, Stecher D, Orduna T, Bentancourt S, Jiménez SG, Flynn LP, Arce GP, Uboldi MA, Bugna L, Morales MA, Digilio C, Fabbri C, Enría D, Diosque M, Vizzotti C. Yellow fever vaccine-associated adverse events following extensive immunization in Argentina.  Vaccine. 2014 Jan 20. [Epub ahead of print].

22. Bodemer C, Sauvage V, Mahlaoui N, Cheval J, Couderc T, Leclerc-Mercier S, Debré M, Pellier I, Gagnieur L, Fraitag S, Fischer A, Blanche S, Lecuit M, Eloit  M. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency. Clin Microbiol Infect. 2014 Jan 30. [Epub ahead of print].

23. Borgmann S, Schwab F, Santibanez S, Mankertz A. Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study. Epidemiol Infect. 2014 Jan 15:1-9. [Epub ahead of print].

24. Bourdette D, Naismith RT. BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity. Neurology. 2014 Jan 7;82(1):15-6.

25. Braeckman T, Lernout T, Top G, Paeps A, Roelants M, Hoppenbrouwers K, Van Damme P, Theeten H. Assessing vaccination coverage in infants, survey studies versus the Flemish immunisation register: Achieving the best of both worlds. Vaccine. 2014 Jan 9;32(3):345-9.

26. Brotherton JM, Liu B, Donovan B, Kaldor JM, Saville M. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey. Vaccine. 2014 Jan 23;32(5):592-7.

27. Brown AF, Leech JM, Rogers TR, McLoughlin RM. Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design. Front Immunol. 2014 Jan 8;4:507.

28. Brown DS, Arnold SE, Asay G, Lorick SA, Cho BH, Basurto-Davila R, Messonnier  ML. Parent attitudes about school-located influenza vaccination clinics. Vaccine. 2014 Jan 15. [Epub ahead of print].

29. Brown J, Baisley K, Kavishe B, Changalucha J, Andreasen A, Mayaud P, Gumodoka B, Kapiga S, Hayes R, Watson-Jones D. Impact of malaria and helminth infections on immunogenicity of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Tanzania. Vaccine. 2014 Jan 23;32(5):611-7.

30. Böhmer MM, Walter D, Ehrhardt J, Reiter S, Krause G, Wichmann O. [Seasonal and Pandemic Influenza Vaccination: Coverage and Attitude among Private Physicians in Germany]. Gesundheitswesen. 2014 Jan;76(1):44-7.

31. Cadusseau J, Ragunathan-Thangarajah N, Surenaud M, Hue S, Authier FJ, Gherardi RK. Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal  acrophagic Myofasciitis and ASIA. Curr Med Chem. 2014;21(4):511-7.

32. Camargo-Ángeles R, Villanueva-Ruiz CO, García-Román V, Mendoza-García JL, Conesa-Peñuela FJ, Tenza Iglesias I, García Shimizu P, Sánchez-Payá J. [Evaluation of a novel flu vaccination campaign among health personnel for the 2011-2012 season]. Arch Prev Riesgos Labor. 2014 Jan-Mar;17(1):26-30.

33. Carrico RM, Sorrells N, Westhusing K, Wiemken T. Monitoring of health care personnel employee and occupational health immunization program practices in the United States. Am J Infect Control. 2014 Jan;42(1):66-8.

34. Cha SH, Shin SH, Lee TJ, Kim CH, Povey M, Kim HM, Nicholson O. Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children. Clin Exp Vaccine Res. 2014 Jan;3(1):91-9.

35. Charland KM, de Montigny L, Brownstein JS, Buckeridge DL. Clinic accessibility and clinic-level predictors of the geographic variation in 2009 pandemic influenza vaccine coverage in Montreal, Canada. Influenza Other Respir Viruses. 2014 Jan 2. [Epub ahead of print].

36. Chung EH. Vaccine allergies. Clin Exp Vaccine Res. 2014 Jan;3(1):50-57. Epub  2013 Dec 18. Review.

37. Chyu KY, Shah PK. Can we vaccinate against atherosclerosis? J Cardiovasc Pharmacol Ther. 2014 Jan;19(1):77-82.

38. Clemens J, Holmgren J. When, How, and Where Can Oral Cholera Vaccines be Used to Interrupt Cholera Outbreaks? Curr Top Microbiol Immunol. 2014 Jan 9. [Epub ahead of print].

39. Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S109-18.

40. Davila-Payan C, Swann J, Wortley PM. System factors to explain 2009 pandemic  H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic. Vaccine. 2014 Jan 3;32(2):246-51.

41. Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL. Systematic review  of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S119-29.

42. Demuth PC, Min Y, Irvine DJ, Hammond PT. Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization. Adv Healthc Mater. 2014 Jan;3(1):47-58.

43. Denis F, Cohen R, Stahl JP, Martinot A, Dury V, Le Danvic M, Gaudelus J. Papillomavirus vaccination in France according to 2008 to 2012 Vaccinoscopie(®) data. Med Mal Infect. 2014 Jan;44(1):18-24.

44. Dhédin N, Krivine A, Le Corre N, Mallet A, Lioure B, Bay JO, Rubio MT, Agape P, Thiébaut A, Le Goff J, Autran B, Ribaud P. Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients. Vaccine. 2014 Jan 23;32(5):585-91.

45. Ditkowsky JB, Schwartzman K. Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa - implications for clinical trials: a decision analysis. PLoS One. 2014 Jan 15;9(1):e83526.

46. Duque J, McMorrow ML, Cohen AL. Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist? BMC Public Health. 2014 Jan 16;14(1):41.

47. Esposito S, Durando P, Bosis S, Ansaldi F, Tagliabue C, Icardi G; for the ESCMID Vaccine Study Group (EVASG). Vaccine-preventable diseases: From paediatric to adult targets. Eur J Intern Med. 2014 Jan 2. [Epub ahead of print].

48. Fernandes AP, Canavaci AM, McCall LI, Matlashewski G. A2 and other visceralizing proteins of leishmania: role in pathogenesis and application for vaccine development. Subcell Biochem. 2014;74:77-101.

49. Finco O, Rappuoli R. Designing Vaccines for the Twenty-First Century Society. Front Immunol. 2014 Jan 23;5:12.

50. Fischer NJ. Haemophilus influenzae serotype a septic arthritis in an immunized central Australian indigenous child. Int J Infect Dis. 2014 Jan 7. [Epub ahead of print].

51. Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, Goldblatt D, Whitney CG, O'Brien KL. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S152-60.

52. Freiesleben de Blasio B, Flem E, Latipov R, Kuatbaeva A, Kristiansen IS. Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan. Emerg Infect Dis. 2014 Jan;20(1):29-37.

53. Furman D, Hejblum BP, Simon N, Jojic V, Dekker CL, Thiébaut R, Tibshirani RJ, Davis MM. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):869-74.

54. Gaglani M, Spencer S, Ball S, Song J, Naleway A, Henkle E, Bozeman S, Reynolds S, Sessions W, Hancock K, Thompson M. Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine. J Infect Dis. 2014 Jan 12. [Epub ahead of print].

55. Gandhi G, Lydon P. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts. BMC Public Health. 2014 Jan 22;14(1):67.

56. Gargano LM, Herbert NL, Painter JE, Sales JM, Vogt TM, Morfaw C, Jones LM, Murray D, Diclemente RJ, Hughes JM. Development, Theoretical Framework, and Evaluation of a Parent and Teacher-Delivered Intervention on Adolescent Vaccination. Health Promot Pract. 2014 Jan 17. [Epub ahead of print].

57. Gasparini R, Amicizia D, Domnich A, Lai PL, Panatto D. Neisseria meningitides B vaccines: recent advances and possible immunization policies. Expert Rev Vaccines. 2014 Jan 29. [Epub ahead of print].

58. Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Marín-García P, Gil-de-Miguel A. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014 Jan 3;32(2):277-83.

59. Glass RI, Parashar UD. Rotavirus Vaccines - Balancing Intussusception Risks and Health Benefits. N Engl J Med. 2014 Jan 14. [Epub ahead of print].

60. Glass RI, Parashar U, Patel M, Gentsch J, Jiang B. Rotavirus vaccines: successes and challenges. J Infect. 2014 Jan;68 Suppl 1:S9-18.

61. Gorczyca D, Schwirten U. Sensorimotor polyneuropathy after hexavalent vaccination. Scand J Infect Dis. 2014 Jan;46(1):66-8.

62. Goren A, Roberts C, Victor TW. Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil. Expert Rev Vaccines. 2014 Jan;13(1):175-84.

63. Grabenstein JD, Weber DJ. Pneumococcal Serotype Diversity Among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake. Clin Infect Dis. 2014 Jan 12. [Epub ahead of print].

64. Greenberg DP, Robertson CA, Landolfi VA, Bhaumik A, Senders SD, Decker MD. Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age. Pediatr Infect Dis J. 2014 Jan 17. [Epub ahead of print].

65. Guvenel AK, Chiu C, Openshaw PJ. Current concepts and progress in RSV vaccine development. Expert Rev Vaccines. 2014 Jan 9. [Epub ahead of print].

66. Haer-Wigman L, Ait Soussan A, Ligthart P, de Haas M, van der Schoot CE. Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan-phenotypes. Transfusion. 2014 Jan 24. [Epub ahead of print].

67. Hansen S, Lehr CM. Transfollicular delivery takes root: the future for vaccine design? Expert Rev Vaccines. 2014 Jan;13(1):5-7.

68. Haque R, Snider C, Liu Y, Ma JZ, Liu L, Nayak U, Mychaleckyj JC, Korpe P, Mondal D, Kabir M, Alam M, Pallansch M, Oberste MS, Weldon W, Kirkpatrick BD, Petri WA Jr. Oral polio vaccine response in breast fed infants with malnutrition  and diarrhea. Vaccine. 2014 Jan 16;32(4):478-82. 

69. Harper DM, Verdenius I, Harris GD, Barnett AL, Rosemergey B, Arey AM, Wall J, Malnar GJ. The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series. Prev Med. 2014 Jan 15. [Epub ahead of print].

70. Harris T, Williams DM, Fediurek J, Scott T, Deeks SL. Adverse events following immunization in Ontario's female school-based HPV program. Vaccine. 2014 Jan 15. [Epub ahead of print].

71. Heidebrecht CL, Kwong JC, Finkelstein M, Quan SD, Pereira JA, Quach S, Deeks SL. Electronic immunization data collection systems: application of an evaluation framework. BMC Med Inform Decis Mak. 2014 Jan 14;14(1):5.

72. Hibbs BF, Miller ER, Shimabukuro T; Immunization Safety Office, Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC. Notes from the field: rotavirus vaccine administration errors - United States, 2006-2013. MMWR Morb Mortal Wkly Rep. 2014 Jan31;63(4):81.

73. Hollm-Delgado MG, Stuart EA, Black RE. Acute Lower Respiratory Infection Among Bacille Calmette-Guerin (BCG)-Vaccinated Children. Pediatrics. 2014 Jan;133(1):e73-81.

74. Hoschler K, Andrews NJ, Faust SN, Finn A, Pollard AJ, Snape MD, Walker WT, Zambon M, Miller E. Administration of AS03B-adjuvanted A(H1N1)pdm09 Vaccine in Children Aged <3 Years Enhances Antibody Response to H3 and B Viruses Following a Single Dose of Trivalent Vaccine One Year Later. Clin Infect Dis. 2014 Jan;58(2):181-7.

75. Huber VC. Influenza vaccines: from whole virus preparations to recombinant protein technology. Expert Rev Vaccines. 2014 Jan;13(1):31-42.

76. Humiston SG, Schaffer SJ, Szilagyi PG, Long CE, Chappel TR, Blumkin AK, Szydlowski J, Kolasa MS. Seasonal influenza vaccination at school: a randomized controlled trial. Am J Prev Med. 2014 Jan;46(1):1-9.

77. Ibuka Y, Li M, Vietri J, Chapman GB, Galvani AP. Free-riding behavior in vaccination decisions: an experimental study. PLoS One. 2014 Jan 24;9(1):e87164.  

78. Iwai-Itamochi M, Yoshida H, Obara-Nagoya M, Horimoto E, Kurata T, Takizawa T. Development of real-time PCR to detect oral vaccine-like poliovirus and its application to environmental surveillance. J Virol Methods. 2014 Jan;195:148-55.

79. Jackson ML, Henrikson NB, Grossman DC. Evaluating Washington State's Immunization Information System as a Research Tool. Acad Pediatr. 2014 Jan-Feb;14(1):71-6.

80. Jadhav S, Gautam M, Gairola S. Role of developing countries vaccine manufacturers towards global health care by proving quality vaccines at affordable prices. Clin Microbiol Infect. 2014 Jan 29. [Epub ahead of print].

81. Jaiyeoba O, Villers M, Soper DE, Korte J, Salgado CD. Association between health care workers' knowledge of influenza vaccine and vaccine uptake. Am J Infect Control. 2014 Jan;42(1):69-70.

82. Jamil RK, Taqavian M, Sadigh ZA, Shahkarami MK, Esna-Ashari F, Hamkar R, Hosseini SM, Hatami A. Evaluation of the thermal stability of a novel strain of live-attenuated mumps vaccine (RS-12 strain) lyophilized in different stabilizers. J Virol Methods. 2014 Jan 22. [Epub ahead of print].

83. Jentes ES, Blanton JD, Johnson KJ, Petersen BW, Lamias MJ, Robertson K, Franka R, Muhm D, Rupprecht CE, Marano N, Brunette GW. The global availability of rabies immune globulin and rabies vaccine in clinics providing indirect care to travelers. J Travel Med. 2014 Jan;21(1):62-6.

84. Jiménez-García R, Rodríguez-Rieiro C, Hernandez-Barrera V, Carrasco Garrido P, López de Andres A, Esteban-Vasallo MD, Domínguez-Berjón MF, Astray-Mochales J. Negative trends from 2008/9 to 2011/12 seasons in influenza vaccination coverages among high risk subjects and health care workers in Spain. Vaccine. 2014 Jan 9;32(3):350-4.

85. Kansagra SM, Papadouka V, Geevarughese A, Hansen MA, Konty KJ, Zucker JR. Reaching children never previously vaccinated for influenza through a school-located vaccination program. Am J Public Health. 2014 Jan;104(1):e45-9.

86. Kapetanovic MC, Kristensen LE, Saxne T, Aktas T, Mörner A, Geborek P. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis. Arthritis Res Ther. 2014 Jan 2;16(1):R2. [Epub ahead of print].

87. Karmakar S, Zhang W, Ahmad G, Torben W, Alam MU, Le L, Damian RT, Wolf RF, White GL, Carey DW, Carter D, Reed SG, Siddiqui AA. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine. 2014 Jan 4. [Epub ahead of print].

88. Kattan JA, Kudish KS, Cadwell BL, Soto K, Hadler JL. Effect of vaccination coordinators on socioeconomic disparities in immunization among the 2006 Connecticut birth cohort. Am J Public Health. 2014 Jan;104(1):e74-81.

89. Khawaja S, Cardellino A, Mast TC. Hospital-based surveillance and analysis of genotype variation in nicaragua after the introduction of the pentavalent rotavirus vaccine. Pediatr Infect Dis J. 2014 Jan;33(1):e25-8.

90. Kim YH, Kim KA, Kim YR, Choi MK, Kim HK, Choi KJ, Chun JH, Cha K, Hong KJ, Lee NG, Yoo CK, Oh HB, Kim TS, Rhie GE. Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine. Proteomics. 2014 Jan;14(1):93-104.

91. Klaiman T, O'Connell K, Stoto MA. Learning from successful school-based vaccination clinics during 2009 pH1N1. J Sch Health. 2014 Jan;84(1):63-9.

92. Kobayashi T, Hasui K. Efficient immunization strategies to prevent financial contagion. Sci Rep. 2014 Jan 23;4:3834.

93. Koellhoffer JF, Higgins CD, Lai JR. Protein engineering strategies for the development of viral vaccines and immunotherapeutics. FEBS Lett. 2014 Jan 21;588(2):298-307.

94. Kogure T, Harada N, Tatsumi T, Fujinaga H. Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis. Clin Rheumatol. 2014 Jan 21. [Epub ahead of print].

95. Kojima Y, Ohashi H, Nakamura T, Nakamura H, Yamamoto H, Miyata Y, Iida H, Nagai H. Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination. Blood Coagul Fibrinolysis. 2014 Jan 24. [Epub ahead of print].

96. Krajden M, Cook D, Yu A, Chow R, Su Q, Mei W, McNeil S, Money D, Dionne M, Palefsky J, Karunakaran K, Kollmann T, Ogilvie G, Petric M, Dobson S. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial. Vaccine. 2014 Jan 23;32(5):624-30.

97. Kulkarni PS, Agarkhedkar S, Lalwani S, Bavdekar AR, Jog S, Raut SK, Parulekar V, Agarkhedkar SS, Palkar S, Mangrule S. Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine: A case control study. Hum Vaccin Immunother. 2014 Jan 9;10(3). [Epub ahead of print].

98. Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. Epidemiol Infect. 2014 Jan;142(1):12-9.

99. Lambert ND, Haralambieva IH, Ovsyannikova IG, Larrabee BR, Pankratz VS, Poland GA. Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts. Immunol Res. 2014 Jan;58(1):1-8.

100. Lankisch P, Laws HJ, Weiss M, Borkhardt A. Agammaglobulinemia and lack of immunization protection in exudative atopic dermatitis. Eur J Pediatr. 2014 Jan;173(1):117-9.

101. Laryea DO, Abbeyquaye Parbie E, Frimpong E. Timeliness of childhood vaccine uptake among children attending a tertiary health service facility-based immunisation clinic in Ghana. BMC Public Health. 2014 Jan 29;14(1):90. [Epub ahead of print].

102. Lavinder JJ, Wine Y, Giesecke C, Ippolito GC, Horton AP, Lungu OI, Hoi KH, Dekosky BJ, Murrin EM, Wirth MM, Ellington AD, Dörner T, Marcotte EM, Boutz DR, Georgiou G. Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A. 2014 Jan 27. [Epub ahead of print].

103. Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Vaccine. 2014 Jan 14. [Epub ahead of print].

104. Le Meur JB, Lefebvre B, Proulx JF, Déry S, Pépin J, De Wals P. Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010. Int J Circumpolar Health. 2014 Jan 17;73.

105. Le Polain de Waroux O, Flasche S, Prieto-Merino D, Edmunds WJ. Age-Dependent

Prevalence of Nasopharyngeal Carriage of Streptococcus pneumoniae before Conjugate Vaccine Introduction: A Prediction Model Based on a Meta-Analysis. PLoS One. 2014 Jan 23;9(1):e86136.

106. Lee SW, Oh SY, Lee JB, Choi CM, Kim HJ. Tuberculin Skin Test Distribution following a Change in BCG Vaccination Policy. PLoS One. 2014 Jan 23;9(1):e86419.

107. Legge A, Dodds L, Macdonald NE, Scott J, McNeil S. Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ. 2014 Jan 13. [Epub ahead of print].

108. Lernout T, Theeten H, Hens N, Braeckman T, Roelants M, Hoppenbrouwers K, Van Damme P. Timeliness of infant vaccination and factors related with delay in Flanders, Belgium. Vaccine. 2014 Jan 3;32(2):284-9.

109. Lim YC, Seale H. Examining the views of key stakeholders regarding the provision of occupational influenza vaccination for healthcare workers in Australia. Vaccine. 2014 Jan 23;32(5):606-10. 

110. Linhares AC, Justino MC. Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction. Expert Rev Vaccines. 2014 Jan;13(1):43-57.

111. Liu X, Walton S, Mounsey K. Vaccine against scabies: necessity and possibility. Parasitology. 2014 Jan 28:1-8. [Epub ahead of print].

112. Livingston KA, Rosen JB, Zucker JR, Zimmerman CM. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City. Vaccine. 2014 Jan 9;32(3):369-74.

113. Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, Coleman JD, Rose JK, Nichol ST, Spiropoulou CF. Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antiviral Res. 2014 Jan;101:26-9.

114. Loo JD, Conklin L, Deloria Knoll M, Fleming-Dutra KE, Park DE, Kirk J, Johnson TS, Goldblatt D, O'Brien KL, Whitney CG. Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S182-7.

115. Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S140-51.

116. Lu PJ, Graitcer SB, O'Halloran A, Liang JL. Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel-United States, 2011. Vaccine. 2014 Jan 23;32(5):572-8.

117. Lu Y, Welsh JP, Swartz JR. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines. Proc Natl Acad Sci U S A. 2014 Jan;111(1):125-30.

118. Luchs A, Cilli A, Morillo SG, de Cassia Compagnoli Carmona R, do Carmo Sampaio Tavares Timenetsky M. Rotavirus in adults, Brazil, 2004-2011: G2P[4] dominance and potential impact on vaccination. Braz J Infect Dis. 2014 Jan-Feb;18(1):53-9.

119. Macdonald SE, Schopflocher DP, Golonka RP. The pot calling the kettle black: the extent and type of errors in a computerized immunization registry and by parent report. BMC Pediatr. 2014 Jan 4;14(1):1.

120. Mahoney R. The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries? Vaccine. 2014 Feb 12;32(8):904-8.

121. Malik B, Rath G, Goyal AK. Are the anatomical sites for vaccine administration selected judiciously? Int Immunopharmacol. 2014 Jan 7;19(1):17-26. [Epub ahead of print].

122. Marshall AS, Barker CI, Pulickal AS, Kibwana E, Gautam SC, Clutterbuck EA, Thorson SM, Shrestha S, Adhikari N, Pollard AJ, Kelly DF. The Seroepidemiology of Haemophilus influenzae Type B Prior to Introduction of an Immunization Programme in Kathmandu, Nepal. PLoS One. 2014 Jan 22;9(1):e85055.

123. Marshall H, Clarke M, Sullivan T. Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines. Vaccine. 2014 Jan 9;32(3):338-44.

124. Martin DW, Lowery NE, Brand B, Gold R, Horlick G. Immunization Information Systems: A Decade of Progress in Law and Policy. J Public Health Manag Pract. 2014 Jan 7. [Epub ahead of print].

125. Martins CL, Benn CS, Andersen A, Balé C, Schaltz-Buchholzer F, Do VA, Rodrigues A, Aaby P, Ravn H, Whittle H, Garly ML. A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions. J Infect Dis. 2014 Jan 16. [Epub ahead of print].

126. Marzook NB, Procter DJ, Lynn H, Yamamoto Y, Horsington J, Newsome TP. Methodology for the efficient generation of fluorescently tagged vaccinia virus proteins. J Vis Exp. 2014 Jan 17;(83).

127. Mathew R, Mason D, Kennedy JS. Vaccination issues in patients with chronic kidney disease. Expert Rev Vaccines. 2014 Feb;13(2):285-98.

128. McColloster PJ, Martin-de-Nicolas A. Vaccine refrigeration: Thinking outside of the box. Hum Vaccin Immunother. 2014 Jan 17;10(4). [Epub ahead of print].

129. McGarry LJ, Krishnarajah G, Hill G, Masseria C, Skornicki M, Pruttivarasin N, Arondekar B, Roiz J, Pelton SI, Weinstein MC. Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission. PLoS One. 2014 Jan 9;9(1):e72723.

130. McLean HQ, Meece JK, Belongia EA. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. Vaccine. 2014 Jan 16;32(4):453-7.

131. McQuaid F, Snape MD. Will booster doses be required for serogroup B meningococcal vaccine? Expert Rev Vaccines. 2014 Jan 23. [Epub ahead of print].

132. Merler S, Ajelli M. Deciphering the relative weights of demographic transition and vaccination in the decrease of measles incidence in Italy. Proc Biol Sci. 2014 Jan 8;281(1777):20132676.

133. Mills B, Fensterheim L, Taitel M, Cannon A. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital. Vaccine. 2014 Jan 16;32(4):521-5.

134. Minetti A, Hurtado N, Grais RF, Ferrari M. Reaching Hard-to-Reach Individuals: Nonselective Versus Targeted Outbreak Response Vaccination for Measles. Am J Epidemiol. 2014 Jan 15;179(2):245-51.

135. Miravalle AA, Schreiner T. Neurologic complications of vaccinations. Handb Clin Neurol. 2014;121:1549-57.

136. Mo AX, Agosti JM, Walson JL, Hall BF, Gordon L. Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals. Am J Trop Med Hyg. 2014 Jan;90(1):54-60.

137. Mollard EK, Guenzel N, Brown PA, Keeler HJ, Cramer ME. Policy Considerations for Improving Influenza Vaccination Rates among Pregnant Women. Public Health Nurs. 2014 Jan 6 [Epub ahead of print].

138. Mosser JF, Grant LR, Millar EV, Weatherholtz RC, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL. Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use. PLoS One. 2014 Jan 17;9(1):e79578.

139. Mpabalwani EM, Chitambala P, Chibumbya JN, Matapo B, Mutambo H, Mwenda JM, Babaniyi O, Munkonge L. Intussusception incidence rates in 9 zambian hospitals, 2007-2011: prerotavirus vaccine introduction. Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S94-8.

140. Murugappan S, Patil HP, Frijlink HW, Huckriede A, Hinrichs WL. Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine. AAPS J. 2014 Jan 31. [Epub ahead of print].

141. Mustafa A, Makki A, Siddig O, Haithami S, Teleb N, Trivedi T, Parashar U, Patel M. Baseline burden of rotavirus disease in Sudan to monitor the impact of vaccination. Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S23-7.

142. Mwenda JM, Tate JE, Steele AD, Parashar UD. Preparing for the Scale-up of Rotavirus Vaccine Introduction in Africa: Establishing Surveillance Platforms to Monitor Disease Burden and Vaccine Impact. Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S1-5.

143. Na HN, Kim H, Nam JH. Prophylactic and therapeutic vaccines for obesity. Clin Exp Vaccine Res. 2014 Jan;3(1):37-41.

144. Nath KD, Burel JG, Shankar V, Pritchard AL, Towers M, Looke D, Davies JM, Upham JW. Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2014;9:51-6.

145. Ngabo F, Gatera M, Karema C, Donnen P, Lepage P, Parashar UD, Tate JE, Mwenda JM, Rugambwa C, Binagwaho A. Can Routinely Collected National Data on Childhood Morbidity and Mortality from Diarrhea be Used to Monitor Health Impact of Rotavirus Vaccination in Africa?: Examination of Pre-Vaccine Baseline Data from Rwanda. Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S89-93.

146. Ngendahayo E, Bonane A, Ntakiyiruta G, Munyanshongore A, Muganga N, Bikoroti J, Mwenda JM, Tate JE, Ngabo F. Preparing for Safety Monitoring After Rotavirus Vaccine Implementation: A Retrospective Review of Intussusception Cases among Children at a Large Teaching Hospital in Rwanda, 2009-2012. Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S99-S103.

147. Nguipdop-Djomo P, Mangtani P, Pedrazzoli D, Rodrigues LC, Abubakar I. Uptake of neonatal BCG vaccination in England: performance of the current policy recommendations. Thorax. 2014 Jan;69(1):87-9.

148. O'Connor D, Trück J, Lazarus R, Clutterbuck EA, Voysey M, Jeffery K, Pollard AJ. The Effect of Chronic Cytomegalovirus Infection on Pneumococcal Vaccine Responses. J Infect Dis. 2014 Jan 2. [Epub ahead of print].

149. O'Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program. Drugs. 2014 Jan;74(1):15-30. doi: 10.1007/s40265-013-0155-7.

150. Offutt-Powell TN, Ojha RP, Qualls-Hampton R, Stonecipher S, Singh KP, Cardarelli KM. Parental risk perception and influenza vaccination of children in daycare centres. Epidemiol Infect. 2014 Jan;142(1):134-41.

151. Okeibunor J, Gasasira A, Mihigo R, Salla M, Poy A, Orkeh G, Shaba K, Nshimirimana D. Trend in proportions of missed children during polio supplementary immunization activities in the African Region: Evidence from independent monitoring data 2010-2012. Vaccine. 2014 Jan 14. [Epub ahead of print].

152. Olberg HK, Cox RJ, Nostbakken JK, Aarseth JH, Vedeler CA, Myhr KM. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study. Mult Scler. 2014 Jan 16. [Epub ahead of print].

153. Oleszycka E, Lavelle EC. Immunomodulatory properties of the vaccine adjuvant alum. Curr Opin Immunol. 2014 Jan 22;28C:1-5. [Epub ahead of print].

154. Olives C, Valadez JJ, Pagano M. Estimation after classification using lot quality assurance sampling: corrections for curtailed sampling with application to evaluating polio vaccination campaigns. Trop Med Int Health. 2014 Jan 2. [Epub ahead of print].

155. Ondič O, Kašpírková J, Májek O, Kinkorová I. HPV typing of high-grade dysplasia (CIN III) in cone biopsies of 38 HPV-vaccinated women. Virchows Arch. 2014 Jan;464(1):79-83.

156. Otieno NA, Nyawanda BO, Audi A, Emukule G, Lebo E, Bigogo G, Ochola R, Muthoka P, Widdowson MA, Shay DK, Burton DC, Breiman RF, Katz MA, Mott JA. Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011. Vaccine. 2014 Jan 22. [Epub ahead of print].

157. Ouangraoua S, Schlumberger M, Yaro S, Ouédraogo AS, Sanou S, Drabo A, Yaméogo TM, Ouedraogo R. [Impact of a conjugated anti meningococcal A vaccine on notification of bacterial meningitis in West Burkina Faso (2009-2012).]. Bull Soc Pathol Exot. 2014 Jan 3. [Epub ahead of print].

158. Pakkanen SH, Kantele JM, Herzog C, Kantele A. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae. Vaccine. 2014 Jan 23;32(5):544-51.

159. Pakkanen SH, Kantele JM, Kantele A. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains. Scand J Immunol. 2014 Jan 2 [Epub ahead of print].

160. Park DE, Johnson TS, Nonyane BA, Chandir S, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL, Deloria Knoll M. The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S130-9.

161. Park S, Nahm MH. Correction: L-Rhamnose Is Often an Important Part of Immunodominant Epitope for Pneumococcal Serotype 23F Polysaccharide Antibodies in Human Sera Immunized with PPV23. PLoS One. 2014 Jan 13;9(1).

162. Park SJ, Kim EH, Pascua PN, Kwon HI, Lim GJ, Decano A, Kim SM, Song MK, Shin EC, Choi YK. Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models. J Gen Virol. 2014 Jan 13. [Epub ahead of print].

163. Parrella A, Gold M, Braunack-Mayer A, Baghurst P, Marshall H. Consumer reporting of adverse events following immunization (AEFI): Identifying predictors of reporting an AEFI. Hum Vaccin Immunother. 2014 Jan 9;10(3). [Epub ahead of print].

164. Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: Considerations for school- and non-school based immunization program. Vaccine. 2014 Jan 9;32(3):320-6.

165. Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, Curns AT, Weintraub E, Parashar UD. Protective Association Between Rotavirus Vaccination and Childhood Seizures in the Year Following Vaccination in US Children. Clin Infect Dis. 2014 Jan;58(2):173-7.

166. Peck JL, Stanton M, Reynolds GE. Smartphone preventive health care: parental use of an immunization reminder system. J Pediatr Health Care. 2014 Jan-Feb;28(1):35-42.

167. Perrett KP, John TM, Jin C, Kibwana E, Yu LM, Curtis N, Pollard AJ. Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type b conjugate vaccine in early childhood and response to booster. Clin Infect Dis. 2014 Jan 7. [Epub ahead of print].

168. Petrizzo A, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L. Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach. J Transl Med. 2014 Jan 15;12(1):11.

169. Pitzer VE, Bowles CC, Baker S, Kang G, Balaji V, Farrar JJ, Grenfell BT. Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study. PLoS Negl Trop Dis. 2014 Jan 9;8(1):e2642.

170. Pride KR, Geissler AL, Kolasa MS, Robinson B, Van Houten C, McClinton R, Bryan K, Murphy T. Assessment of Vaccine Exemptions Among Wyoming School Children, 2009 and 2011. J Sch Nurs. 2014 Jan 9. [Epub ahead of print].

171. Pulcini C, Massin S, Launay O, Verger P. Knowledge, attitudes, beliefs and practices of general practitioners towards measles and MMR vaccination in southeastern France in 2012. Clin Microbiol Infect. 2014 Jan;20(1):38-43.

172. Qutaiba B Al-Lela O, Bahari MB, Al-Qazaz HK, Salih MR, Jamshed SQ, Elkalmi RM. Are parents' knowledge and practice regarding immunization related to pediatrics' immunization compliance? a mixed method study. BMC Pediatr. 2014 Jan 25;14(1):20.

173. Rambout L, Tashkandi M, Hopkins L, Tricco AC. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: A systematic review. Prev Med. 2014 Jan;58:22-32.

174. Ratanasiripong NT. Human Papillomavirus Vaccine Increases High-Risk Sexual Behaviors: A Myth or Valid Concern. J Sch Nurs. 2014 Jan 11. [Epub ahead of print].

175. Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev Vaccines. 2014 Jan 6. [Epub ahead of print].

176. Rivas-Santiago B, Cervantes-Villagrana AR. Novel approaches to tuberculosis prevention: DNA vaccines. Scand J Infect Dis. 2014 Jan 23. [Epub ahead of print].

177. Rose MA, Damm O, Greiner W, Knuf M, Wutzler P, Liese JG, Krüger H, Wahn U, Schaberg T, Schwehm M, Kochmann TF, Eichner M. The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. BMC Infect Dis. 2014 Jan 22;14(1):40.

178. Rousseau MC, Conus F, Li J, Parent MÉ, El-Zein M. The Québec BCG Vaccination Registry (1956-1992): assessing data quality and linkage with administrative health databases. BMC Med Inform Decis Mak. 2014 Jan 9;14(1):2.

179. Rudenko L, Isakova-Sivak I, Rekstin A. H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic? Expert Rev Vaccines. 2014 Jan;13(1):1-4.

180. Rysavy MB, Kresowik JD, Liu D, Mains L, Lessard M, Ryan GL. Human Papillomavirus Vaccination and Sexual Behavior in Young Women. J Pediatr Adolesc Gynecol. 2014 Jan 6. [Epub ahead of print].

181. Saydam M, Rigsby P, Mawas F. A novel Enzyme-Linked Immuno-Sorbent Assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae b-Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations. Biologicals. 2014 Jan;42(1):29-33.

182. Scherk MA, Ford RB, Gaskell RM, Hartmann K, Hurley KF, Lappin MR, Levy JK, Little SE, Nordone SK, Sparkes AH. 2013 AAFP Feline Vaccination Advisory Panel Report. J Feline Med Surg. 2014 Jan;16(1):66.

183. Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Serum 25-hydroxyvitamin d level and influenza vaccine immunogenicity in children and adolescents. PLoS One. 2014 Jan 10;9(1):e83553.

184. Seligman SJ, Cohen JE, Itan Y, Casanova JL, Pezzullo JC. Defining Risk Groups to Yellow Fever Vaccine-Associated Viscerotropic Disease in the Absence of Denominator Data. Am J Trop Med Hyg. 2014 Jan 6. [Epub ahead of print].

185. Sengler C, Niewerth M, Kallinich T, Nimtz-Talaska A, Haller M, Huppertz HI, Minden K. Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases. Clin Rheumatol. 2014 Jan;33(1):137-9.

186. Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014 Feb;13(2):235-46.

187. Shcherbik S, Sergent SB, Davis WG, Shu B, Barnes J, Kiseleva I, Larionova N, Klimov A, Bousse T. Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production. J Virol Methods. 2014 Jan;195:18-25.

188. Shen AK, O'Grady MJ, McDevitt RD, Pickreign JD, Laudenberger LK, Esber A, Shortridge EF. How Might Immunization Rates Change if Cost Sharing Is Eliminated? Public Health Rep. 2014 Jan;129(1):39-46.

189. Shi JQ, Chen QX, Li SF, Li W. Hydroa vacciniforme-like cutaneous T-cell lymphoma. Indian J Dermatol. 2014 Jan;59(1):91-3.

190. Siddiqui NT, Owais A, Agha A, Karim MS, Zaidi AK. Ethnic disparities in routine immunization coverage: a reason for persistent poliovirus circulation in karachi, pakistan? Asia Pac J Public Health. 2014 Jan;26(1):67-76.

191. Sigurdardottir ST, Center KJ, Davidsdottir K, Arason VA, Hjalmarsson B, Elisdottir R, Ingolfsdottir G, Northington R, Scott DA, Jonsdottir I. Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children. Vaccine. 2014 Jan 9;32(3):417-24.

192. Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-12 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis. 2014 Jan 19. [Epub ahead of print].

193. Standaert BA, Curran D, Postma MJ. Budget constraint and vaccine dosing: a mathematical modelling exercise. Cost Eff Resour Alloc. 2014 Jan 22;12(1):3.

194. Stewart AM, Lindley MC, Chang KH, Cox MA. Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States. Vaccine. 2014 Jan 23;32(5):618-23.

195. Stockwell MS, Broder K, Larussa P, Lewis P, Fernandez N, Sharma D, Barrett A, Sosa J, Vellozzi C. Risk of Fever After Pediatric Trivalent Inactivated Influenza Vaccine and 13-Valent Pneumococcal Conjugate Vaccine. JAMA Pediatr. 2014 Jan 6. doi: 10.1001/jamapediatrics.2013.4469. [Epub ahead of print].

196. Storie EB, Perry A. Erythema multiforme following smallpox vaccination. Mil Med. 2014 Jan;179(1):e113-5.

197. Story A, Aldridge RW, Gray T, Burridge S, Hayward AC. Influenza vaccination, inverse care and homelessness: cross-sectional survey of eligibility and uptake during the 2011/12 season in London. BMC Public Health. 2014 Jan 16;14(1):44.

198. Streng A, Liese JG. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles-mumps-rubella. Vaccine. 2014 Feb 12;32(8):897-900.

199. Stubbs BW, Panozzo CA, Moss JL, Reiter PL, Whitesell DH, Brewer NT. Evaluation of an Intervention Providing HPV Vaccine in Schools. Am J Health Behav. 2014 Jan;38(1):92-102.

200. Stübgen JP. A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev. 2014 Jan;13(1):31-9.

201. Suh H, Shin J, Kim YC. Microneedle patches for vaccine delivery. Clin Exp Vaccine Res. 2014 Jan;3(1):42-49.

202. Takeuchi J, Goto M, Kawamura T, Hiraide A. Serological assessment of measles-rubella vaccination catch-up campaign among university students. Pediatr Int. 2014 Jan 13. [Epub ahead of print].

203. Talukdar S, Zutshi S, Prashanth KS, Saikia KK, Kumar P. Identification of Potential Vaccine Candidates Against Streptococcus pneumoniae by Reverse Vaccinology Approach. Appl Biochem Biotechnol. 2014 Jan 31. [Epub ahead of print].

204. Tan Y, Tamayo P, Nakaya H, Pulendran B, Mesirov JP, Haining WN. Gene signatures related to B-cell proliferation predict influenza vaccine-induced antibody response. Eur J Immunol. 2014 Jan;44(1):285-95.

205. Tebbens RJ, Kalkowska DA, Wassilak SG, Pallansch MA, Cochi SL, Thompson KM. The potential impact of expanding target age groups for polio immunization campaigns. BMC Infect Dis. 2014 Jan 29;14(1):45. [Epub ahead of print].

206. Thomas HL, Andrews N, Green HK, Boddington NL, Zhao H, Reynolds A, McMenamin J, Pebody RG. Estimating vaccine effectiveness against severe influenza in England and Scotland 2011/2012: applying the screening method to data from intensive care surveillance systems. Epidemiol Infect. 2014 Jan;142(1):126-33.

207. Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergström J, Ljungman M, Törner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C. A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine -BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers. PLoS One. 2014 Jan 8;9(1):e83449.

208. Tom JO, Chen C, Zhou YY. Personal health record use and association with immunizations and well-child care visits recommendations. J Pediatr. 2014 Jan;164(1):112-7.

209. Tomimatsu K, Shirahata S. Antigen-specific in vitro immunization: a source for human monoclonal antibodies. Methods Mol Biol. 2014;1060:297-307.

210. Tozzi AE, Piga S, Corchia C, Di Lallo D, Carnielli V, Chiandotto V, Fertz MC, Miniaci S, Rusconi F, Cuttini M. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: Results of the ACTION follow-up project. Vaccine. 2014 Feb 7;32(7):793-9.

211. Troy SB, Ferreyra-Reyes L, Huang C, Sarnquist C, Canizales-Quintero S, Nelson C, Báez-Saldaña R, Holubar M, Ferreira-Guerrero E, García-García L, Maldonado YA. Community Circulation Patterns of Oral Polio Vaccine Serotypes 1, 2, and 3 After Mexican National Immunization Weeks. J Infect Dis. 2014 Jan 19. [Epub ahead of print].

212. Tseng HF, Schmid DS, Harpaz R, Larussa P, Jensen NJ, Rivailler P, Radford K, Folster J, Jacobsen SJ. Herpes zoster caused by vaccine strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis. 2014 Jan 26. [Epub ahead of print].

213. Ueno M, Ishii Y, Tateda K, Anahara Y, Ebata A, Iida M, Mizuno F, Inamura S, Takahata K, Suzuki Y, Chang B, Wada A, Sugita M, Tanaka T, Nishiwaki Y. Changes in Streptococcus pneumoniae Serotypes in the Nasopharynx of Japanese Children after Inoculation with a Heptavalent Pneumococcal Conjugate Vaccine. Jpn J Infect Dis. 2014;67(1):40-3.

214. Ulman CA, Trevino JJ, Gandhi RK. Herpes zoster in a 2-year-old vaccinated against varicella. Dermatol Online J. 2014 Jan 15;20(1):21259.

215. Uphoff H, Wirtz A, Jahn K, Hauri AM. [Pandemic 2009/10: reflections on the utility of the vaccination actions in hesse]. Gesundheitswesen. 2014 Jan;76(1):48-55.

216. van de Vooren K, Duranti S, Curto A, Garattini L. Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies. Pharmacoeconomics. 2014 Jan;32(1):29-45.

217. van der Maaden K, Trietsch SJ, Kraan H, Varypataki EM, Romeijn S, Zwier R, van der Linden HJ, Kersten G, Hankemeier T, Jiskoot W, Bouwstra J. Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats. Pharm Res. 2014 Jan 28. [Epub ahead of print].

218. van der Velden MV, Fritz R, Pöllabauer EM, Portsmouth D, Howard MK, Kreil TR, Dvorak T, Fritsch S, Vesikari T, Diez-Domingo J, Richmond P, Lee BW, Kistner O, Ehrlich HJ, Barrett PN, Aichinger G. Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population. J Infect Dis. 2014 Jan;209(1):12-23.

219. Varan AK, Esteves-Jaramillo A, Richardson V, Esparza-Aguilar M, Cervantes-Powell P, Omer SB. Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City. Vaccine. 2014 Feb 7;32(7):785-92.

220. Vellozzi C, Iqbal S, Broder K. Guillain-Barre Syndrome, Influenza and Influenza Vaccination--the Epidemiologic Evidence. Clin Infect Dis. 2014 Jan 9. [Epub ahead of print].

221. Wahid R, Zafar SJ, McArthur MA, Pasetti MF, Levine MM, Sztein MB. Live oral Salmonella Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi B. Clin Vaccine Immunol. 2014 Jan 15. [Epub ahead of print].

222. Wang J, Munshi KD, Hong SH. Racial and ethnic disparities in influenza vaccinations among community pharmacy patients and non-community pharmacy respondents. Res Social Adm Pharm. 2014 Jan-Feb;10(1):126-40.

223. Ward J, Raude J. Understanding influenza vaccination behaviors: a comprehensive sociocultural framework. Expert Rev Vaccines. 2014 Jan;13(1):17-29.

224. Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, Destefano F. Risk of Intussusception after Monovalent Rotavirus Vaccination. N Engl J Med. 2014 Jan 14. [Epub ahead of print].

225. Whitney CG, Goldblatt D, O'Brien KL. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers. Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S172-81.

226. Williams SE, Vellozzi C, Edwards KM, Moore KL, Sharma D, Creech CB. Evaluation of the feasibility of a state-based vaccine safety advice network. Vaccine. 2014 Feb 12;32(8):901-3.

227. Wilson K, Ducharme R, Ward B, Hawken S. Increased emergency room visits or hospital admissions in females after 12-month MMR vaccination, but no difference after vaccinations given at a younger age. Vaccine. 2014 Jan 15. [Epub ahead of print].

228. Wong VW, Fong DY, Tarrant M. Brief education to increase uptake of influenza vaccine among pregnant women: a study protocol for a randomized controlled trial. BMC Pregnancy Childbirth. 2014 Jan 14;14(1):19.

229. Wood N, Marshall H, White OJ, Holt PG, McIntyre P. Antibody and Cell Mediated Immunity to Pertussis 4 Years after Monovalent Acellular Pertussis Vaccine at Birth. Pediatr Infect Dis J. 2014 Jan 17. [Epub ahead of print].

230. Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, Ackerman ME, van der Avoort H, Steven Oberste M, Pallansch MA, Burton AH, Jaffar MA, Sutter RW. Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination. J Infect Dis. 2014 Jan 23. [Epub ahead of print].

231. Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, Zeng C, Glanz J. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 Jan 9. [Epub ahead of print].

232. Yamazaki T, Ichinohe T. Inflammasomes in antiviral immunity: clues for influenza vaccine development. Clin Exp Vaccine Res. 2014 Jan;3(1):5-11.

233. Yao KH, Yang YH. [Adverse events following immunization and causality assessment of an adverse event following immunization]. Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jan;16(1):1-4. Chinese.

234. Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception Risk after Rotavirus Vaccination in U.S. Infants. N Engl J Med. 2014 Jan 14. [Epub ahead of print].

235. Zakrzewski L, Sur DK, Agrawal N. Staff versus Physician Vaccine Protocols for Influenza Immunization During Pregnancy. J Am Board Fam Med. 2014 Jan-Feb;27(1):56-60.

236. Zawadka M, Mosiej E, Polak M, Krysztopa-Grzybowska K, Moskała B, Rokosz-Chudziak N, Rabczenko D, Augustynowicz E, Lutyńska A. Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland. Biologicals. 2014 Jan 20. [Epub ahead of print].

237. Zhan B, Beaumier CM, Briggs N, Jones KM, Keegan BP, Bottazzi ME, Hotez PJ. Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections. Expert Rev Vaccines. 2014 Jan 6. [Epub ahead of print].

238. Zhao H, Lin ZJ, Huang SJ, Li J, Liu XH, Guo M, Zhang J, Xia NS, Pan HR, Wu T, Li CG. Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination. Hum Vaccin Immunother. 2014 Jan 2;10(3). [Epub ahead of print].

239. Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg AP. Nanoparticle vaccines. Vaccine. 2014 Jan 9;32(3):327-37.

240. Zuccotti G, Mameli C, Daprai L, Garlaschi ML, Dilillo D, Bedogni G, Faccini M, Gramegna M, Torresani E; PneuMi Study Group (PMSG). Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Vaccine. 2014 Jan 23;32(5):527-34.